Quality of life perceptions amongst patients co-infected with Visceral Leishmaniasis and HIV: A qualitative study from Bihar, India

被引:8
|
作者
Nair, Mohit [1 ]
Kumar, Pragya [2 ]
Pandey, Sanjay [2 ]
Kazmi, Shahwar [1 ]
Moreto-Planas, Laura [3 ]
Ranjan, Alok [2 ]
Burza, Sakib [1 ]
机构
[1] Med Sans Frontieres, New Delhi, India
[2] All India Inst Med Sci, Patna, Bihar, India
[3] Med Sans Frontieres, Barcelona, Spain
来源
PLOS ONE | 2020年 / 15卷 / 02期
关键词
IMMUNODEFICIENCY-VIRUS; COINFECTION; CARE;
D O I
10.1371/journal.pone.0227911
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Co-infection with Visceral Leishmaniasis (commonly known as Kala Azar, KA) and Human Immunodeficiency Virus (HIV) is increasingly being diagnosed among patients in Bihar. This qualitative study is the first assessment of self-reported quality of life among patients co-infected with KA-HIV in the Asian context. Methods We conducted semi-structured, in-depth interviews and adopted an inductive thematic analysis to generate evidence on the quality of life of patients co-infected with KA and HIV. Patients were purposively sampled until saturation was attained. Results We found that patients highly valued income or livelihood potential and health as indicators of a good quality life, and routinely went into debt accessing care in the private setup. This was due to perceptions of poor quality of care in the government setup and a lack of knowledge regarding available government services at the district level. KA symptoms were often misdiagnosed in the private sector as seasonal fever, while care providers found it difficult to disentangle the clinical symptoms of KA and HIV; hence, patients presented late to district hospitals. Patients perceived a high level of stigma, largely due to their HIV status, and routinely reported that HIV had "destroyed" their life. Conclusions Inadequate social support and referral pathways that were not conducive to patient needs negatively impacted patients' quality of life. The dual burden of poverty interacting with the severity and chronicity of KA-HIV co-infection means financial support, increased community engagement, and collaborative decision making are crucial for co-infected patients. Increased provider awareness of co-infection and effective stigma-reduction interventions should be integrated to ensure that appropriate and effective access to care is possible for this vulnerable population. A sustainable long-term strategy requires a people-centered approach wherein the perceptions and life circumstances of patients are taken into account in the medical decision making process.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Knowledge, Attitude, and Practices among HIV/Leishmaniasis Co-Infected Patients in Bihar, India
    Devipriya, J. S.
    Gupta, Ashok Kumar
    Pavan, Garapati
    Dhingra, Sameer
    Murti, Krishna
    Ravichandiran, Velayutham
    Pandey, Krishna
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 107 (04): : 789 - 795
  • [2] Biomarkers of disease severity in patients with visceral leishmaniasis co-infected with HIV
    Ferreira, Gabriel Reis
    Santos-Oliveira, Joanna Reis
    Silva-Freitas, Maria Luciana
    Honda, Mariana
    Costa, Dorcas Lamounier
    Da-Cruz, Alda Maria
    Nery Costa, Carlos Henrique
    CYTOKINE, 2022, 149
  • [3] Patient perceptions of new treatment modalities for visceral leishmaniasis in Bihar, India: a qualitative study
    Burza, S.
    Jeleff, M.
    Das, V. R.
    Sunyoto, T.
    Mahajan, R.
    Lima, M. A.
    Boelaert, M.
    Van Geertruyden, J. -P.
    Burtscher, D.
    Das, P.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 211 - 211
  • [4] Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia
    Mohammed, Rezika
    Fikre, Helina
    Schuster, Angela
    Mekonnen, Tigist
    van Griensven, Johan
    Diro, Ermias
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 92
  • [5] Combination treatment for visceral leishmaniasis patients co-infected with human immunodeficiency virus in India
    Burza, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 55 - 55
  • [6] Combination treatment for visceral leishmaniasis patients co-infected with human immunodeficiency virus in India
    Mahajan, R.
    Das, P.
    Isaakidis, P.
    Sunyoto, T.
    Sagili, K. D.
    Lima, M. A.
    Mitra, G.
    Kumar, D.
    Pandey, K.
    Van Geertruyden, J. -P.
    Boelaert, M.
    Burza, S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 207 - 207
  • [7] TUBERCULOSIS IN PATIENTS CO-INFECTED WITH VISCERAL LEISHMANIASIS AND HIV - A NEW DIAGNOSTIC AND MANAGEMENT CHALLENGE
    Burza, S.
    Pandey, K.
    Mahajan, R.
    Kazmi, S.
    Harshana, A.
    Alexander, N.
    Lasry, E.
    Moreto-Planas, L.
    Das, V. N. R.
    Das, P.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 : S150 - S151
  • [8] Epidemiological profile of patients co-infected with visceral leishmaniasis and HIV/AIDS in Northeast, Brazil
    de Castro Viana, Graca Maria
    Custodio Neto da Silva, Marcos Antonio
    de Sousa Garcia, Joao Victor
    Guimaraes, Helaine Dias
    Arcos Junior, Gelson Farias
    Arouche Santos, Augusto Viana
    da Paixao, Pedro Viana
    Soares Brandao Nascimento, Maria do Desterro
    Galvao, Carolina de Souza
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2017, 50 (05) : 613 - 620
  • [9] The risk and predictors of visceral Leishmaniasis relapse in HIV co-infected patients in Ethiopia: a retrospective cohort study
    Abongomera, C.
    Diro, E.
    Vogt, F.
    Tsoumanis, A.
    Mekonnen, Z.
    Admassu, H.
    Colebunders, R.
    Mohammed, R.
    Ritmeijer, K.
    van Griensven, J.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 : 183 - 183
  • [10] TUBERCULOSIS IN PATIENTS CO-INFECTED WITH VISCERAL LEISHMANIASIS AND HIV - A NEW DIAGNOSTIC AND MANAGEMENT CHALLENGE
    Mahajan, R.
    Kazmi, S.
    Pandey, K.
    Harshana, A.
    Alexander, N.
    Moreto-Planas, L.
    Burza, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S7 - S8